Literature DB >> 22432427

Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.

Vincenza Calvaruso1, Amar Paul Dhillon, Emanuel Tsochatzis, Pinelopi Manousou, Federica Grillo, Giacomo Germani, David Patch, James O'Beirne, Andrew Kenneth Burroughs.   

Abstract

BACKGROUND AND AIMS: Current histological scoring systems do not subclassify cirrhosis. Computer-assisted digital image analysis (DIA) of Sirius Red-stained sections measures fibrosis morphologically producing a fibrosis ratio (collagen proportionate area [CPA]). CPA could have prognostic value within a disease stage, such as cirrhosis. The aim of the present study was to evaluate CPA in patients with recurrent hepatitis C virus (HCV) allograft cirrhosis and assess its relationship with hepatic venous pressure gradient (HVPG).
METHODS: In 121 consecutively-transplanted HCV patients with HVPG, measured contemporaneously with transjugular liver biopsies, 65 had Ishak stage 5 or 6 disease (43 with HVPG measurement). Biopsies were stained with Sirius Red for DIA, and the collagen content was expressed as a CPA. In three cases, a tissue for Sirius Red staining was not obtained, and the patients were excluded.
RESULTS: Sixty-two patients were analyzed. The median HVPG was 8 mmHg (interquartile range [IQR]: 5-10). Portal hypertension (HVPG ≥ 6 < 10 mmHg) was present in 30 (69.8%), and HVPG ≥ 10 mmHg in 13 (30.2%). The median CPA was 16% (IQR 10.75-23.25). Median Child-Pugh score and HVPG were not significantly different between Ishak fibrosis stage 5 or 6, whereas CPA was statistically different: 13% in stage 5 (IQR 8.3-12.4) versus 23% in stage 6 (IQR 17-33.7, P < 0.001). In the multivariate analysis, CPA was the only variable significantly associated with clinically-significant portal hypertension (HVPG ≥ 10 mmHg, odds ratio: 1.085, confidence interval: 1.004-1.172, P = 0.040). A CPA of 14% was the best cut-off value for clinically-significant portal hypertension (CSPH) and liver decompensation, which occurred in 24 patients. Event-free survival was significantly shorter in patients with CSPH or with a CPA value ≥ 14%, or with a combination of both.
CONCLUSION: In Ishak stages 5 and 6, CPA correlated with HVPG, but had a wider range of values, suggesting a greater sensitivity for distinguishing "early" from "late" severe fibrosis/cirrhosis. CPA was a unique, independent predictor of HVPG ≥ 10 mmHg. CPA can be used to subclassify cirrhosis and for prognostic stratification.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22432427     DOI: 10.1111/j.1440-1746.2012.07136.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 2.  Enhancing the Value of Histopathological Assessment of Allograft Biopsy Monitoring.

Authors:  Michelle A Wood-Trageser; Andrew J Lesniak; Anthony J Demetris
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 3.  Molecular prognostic prediction in liver cirrhosis.

Authors:  Nicolas Goossens; Shigeki Nakagawa; Yujin Hoshida
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 4.  Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection.

Authors:  Pathik Parikh; John D Ryan; Emmanuel A Tsochatzis
Journal:  Ann Transl Med       Date:  2017-02

Review 5.  Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools.

Authors:  Yan Wang; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2016-01-07       Impact factor: 6.047

6.  The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.

Authors:  Graziella Isgro; Vincenza Calvaruso; Lorenzo Andreana; Tu Vinh Luong; Matteo Garcovich; Pinelopi Manousou; Angela Alibrandi; Sergio Maimone; Laura Marelli; Neil Davies; David Patch; Amar Paul Dhillon; Andrew Kenneth Burroughs
Journal:  J Gastroenterol       Date:  2012-11-03       Impact factor: 7.527

7.  The Relationship Between Collagen Proportionate Area and Hepatitis B Surface Antigen Levels in E Antigen Positive Hepatitis B Cirrhosis.

Authors:  Qiangwei Shi; Rui Yu; Qian Sun; Chunfeng Wang; Jianning Yao; Lianfeng Zhang
Journal:  Turk J Gastroenterol       Date:  2022-01       Impact factor: 1.555

8.  Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.

Authors:  M Lunova; S Frankova; H Gottfriedova; R Senkerikova; M Neroldova; J Kovac; E Kieslichova; V Lanska; E Sticova; J Spicak; M Jirsa; J Sperl
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

9.  Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis.

Authors:  Daniela Cabibi; Fabrizio Bronte; Rossana Porcasi; Sabrina Ingrao; Antonino Giulio Giannone; Marcello Maida; Maria Grazia Bavetta; Salvatore Petta; Vito Di Marco; Vincenza Calvaruso
Journal:  Anal Cell Pathol (Amst)       Date:  2015-11-17       Impact factor: 2.916

10.  Histopathology of post-transplant liver biopsies, the first report from iran.

Authors:  Bita Geramizadeh; Dorna Motevalli; Saman Nikeghbalian; Seyed Ali Malek Hosseini
Journal:  Hepat Mon       Date:  2013-06-18       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.